Biotech

All Articles

ArsenalBio increases $325M, pivots out of previous lead property

.Arsenal Biosciences is going on up. The tissue therapy provider has actually added on $325 thousand...

Lilly- supported fat loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis usage medication fails stage 2b, steering Indivior to re-think $100M choice

.Aelis Farma's chances of getting a quick, positive decision on a $100 thousand possibility repaymen...

ProKidney halts stage 3 trial certainly not required for tissue therapy permission

.ProKidney has stopped one of a pair of stage 3 tests for its tissue treatment for renal disease aft...

Vaxcyte surges on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what professionals named "stunning" phase 1/2 information for its own 31-valent pn...

Recursion's human brain disease test shows little evidence of efficiency

.Recursion has actually stumbled through an early examination of its own tech-enabled approach to dr...

Acepodia, Pfizer click on with each other for chemistry-based cell treatment

.Contact it a situation of great chemistry: Acepodia, a biotech based upon Nobel Champion science, i...

Praxis epilepsy medication reduces seizures in stage 2 trial

.Praxis Preciseness Medicines has actually racked up an additional midphase win in epilepsy this yea...

Three officers surrender as Dyne blog posts blended information for DMD prospect

.After getting away from a medical hold several years back, Dyne Rehab has shown brand new phase 1/2...

Arrowhead fires off stage 3 information in rare metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its hand before a potential face-off along with Ionis, publishi...